Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q3

2269.TEDINET S100Q6O2
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥798.1bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.01T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥770.0bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥64.7bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥79.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥66.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥94.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥82.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥69.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥84.9bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥47.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥87.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥56.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥49.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥61.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.21Tat 2022-12-31Cons.Assets
Total assets¥1.12Tat 2022-03-31Cons.Assets
Total assets¥1.16Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥466.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥404.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥748.1bnat 2022-12-31Cons.Net assets
Net assets / equity¥713.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥696.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥87.7bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥67.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥85.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥60.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥39.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥36.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥127.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥75.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥41.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥27.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥45.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥21.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥77.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥9.8bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥336.242022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.132022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥607.242021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥387.812021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.32021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio58.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-12-31¥649.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-12-31¥649.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥542m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-12-31¥45.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥21.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥798.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥798.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥557m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥66.2bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.1bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2021-04-01 → 2021-12-31¥626.3bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2021-04-01 → 2021-12-31¥625.8bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥503m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2021-04-01 → 2021-12-31¥61.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2021-04-01 → 2021-12-31¥144.4bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2021-04-01 → 2021-12-31¥144.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2021-04-01 → 2021-12-31¥18.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥770.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥770.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥775m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥80.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 522
ItemContextValueUnit
Accrued expensesPrior1YearInstant31474000000JPY
Accrued expensesCurrentQuarterInstant33001000000JPY
Income taxes payablePrior1YearInstant20141000000JPY
Income taxes payableCurrentQuarterInstant5319000000JPY
Contract liabilitiesPrior1YearInstant5907000000JPY
Contract liabilitiesCurrentQuarterInstant1884000000JPY
Return liabilityPrior1YearInstant15929000000JPY
Return liabilityCurrentQuarterInstant24194000000JPY
Provision for bonusesPrior1YearInstant11737000000JPY
Provision for bonusesCurrentQuarterInstant5834000000JPY
Other clPrior1YearInstant65759000000JPY
Other clCurrentQuarterInstant66439000000JPY
Current liabilitiesPrior1YearInstant286811000000JPY
Current liabilitiesCurrentQuarterInstant356680000000JPY
Bonds payablePrior1YearInstant20000000000JPY
Bonds payableCurrentQuarterInstant10000000000JPY
Long term loans payablePrior1YearInstant33039000000JPY
Long term loans payableCurrentQuarterInstant30128000000JPY
Deferred tax liabilitiesPrior1YearInstant5381000000JPY
Deferred tax liabilitiesCurrentQuarterInstant6574000000JPY
Net defined benefit liabilityPrior1YearInstant54662000000JPY
Net defined benefit liabilityCurrentQuarterInstant58216000000JPY
Provision for directors retirement benefitsPrior1YearInstant72000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant72000000JPY
Other nclPrior1YearInstant4469000000JPY
Other nclCurrentQuarterInstant5152000000JPY
Noncurrent liabilitiesPrior1YearInstant117626000000JPY
Noncurrent liabilitiesCurrentQuarterInstant110143000000JPY
LiabilitiesPrior1YearInstant404438000000JPY
LiabilitiesCurrentQuarterInstant466823000000JPY
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant80503000000JPY
Capital surplusCurrentQuarterInstant80609000000JPY
Retained earningsPrior1YearInstant560238000000JPY
Retained earningsCurrentQuarterInstant582872000000JPY
Treasury stockPrior1YearInstant-37868000000JPY
Treasury stockCurrentQuarterInstant-47498000000JPY
Shareholders equityPrior1YearInstant632873000000JPY
Shareholders equityCurrentQuarterInstant645982000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant36347000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant33862000000JPY
Deferred gains or losses on hedgesPrior1YearInstant73000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-61000000JPY
Foreign currency translation adjustmentPrior1YearInstant7673000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant29671000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-3631000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-1847000000JPY
Valuation and translation adjustmentsPrior1YearInstant40462000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant61625000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass